Targeting drugs to combinations of receptors: A modeling analysis of potential specificity

Annals of Biomedical Engineering

Volumn 33, Issue 8, 2005, Pages 1113-1124

  Caplan, Michael R ^a   Rosca, Elena V ^a  

^a Arizona State University   (United States)

Author keywords

Biomaterial; Drug delivery; Mathematical model; Multivalent

Indexed keywords

CELL SURFACE; DRUG DELIVERY; MULTIVALENT; RECEPTORS;

ANTIBODIES; BINDING ENERGY; BIOMATERIALS; CELLS; DATA REDUCTION; MATHEMATICAL MODELS; PARAMETER ESTIMATION;

DRUG PRODUCTS;

CELL SURFACE RECEPTOR; LIGAND;

ANIMAL; ARTICLE; CHEMICAL MODEL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; HUMAN;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; MODELS, CHEMICAL; RECEPTORS, CELL SURFACE;

EID: 23844436235     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-005-5779-1     Document Type: Article

References (23)

1. Al-Kuraya, K., P. Schraml, J. Torhorst, C. Tapia, B. Zaharieva, H. Novotny, H. Spichtin, R. Maurer, M. Mirlacher, O. Kochli, M. Zuber, H. Dieterich, F. Mross, K. Wilber, R. Simon, and G. Sauter. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64(23):8534-8540, 2004.
2. David, A., P. Kopeckova, T. Minko, A. Rubinstein, and J. Kopecek. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Ear. J. Cancer 40:148-157, 2004.
3. Gillies, R. J., and V. J. Hruby. Expression-driven reverse engineering of targeted imaging and therapeutic agents. Expert Opin. Therap. Targets 7(2): 137-139, 2003.
4. Goldstein, B. Desensitization, histamine release and the aggregation of IgE on human basophils. In: Theoretical Immunology, Part One: SFI Studies in the Sciences of Complexity, edited by A. S. Perelson. Redwood City, CA: Addison-Wesley, 1988, pp. 3-40.
5. Handl, H. L., J. Vagner, H. Han, E. Mash, V. J. Hruby, and R. J. Gillies. Hitting multiple targets with multimeric ligands. Expert Opin. Therap. Targets 8(6), 565-586 (22), 200.
6. Hlavacek, W. S., R. G. Posner, and A. S. Perelson. Steric effects on multivalent ligand-receptor binding: Exclusion of ligand sites by bound cell surface receptors. Biophys. J. 76:3031-3043, 1999.
7. Kiessling, L. L., L. E. Strong, and J. E. Gestwicki. Principles for multivalent ligand design. Annu. Rep. Med. Chem. 35:321-330, 2000.
8. Kramer, R. H., and J. W. Karpen. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature 395:710-713, 1998.
9. Lauffenburger, D. A., and J. J. Linderman. Receptors: Models for Binding, Trafficking, and Signaling. New York: Oxford University Press, 1993, 365 pp.
10. Macken, C. A., and A. S. Perelson. Branching Processes Applied to Cell Surface Aggregation Phenomena. Heidelberg: Springer-Verlag, 1985.
11. Mammen, M., S.-K. Choi, and G. M. Whitesides. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Edn. 37:2754-2794, 1998.
12. Mariani, L., C. Beaudry, W. S. McDonough, D. B. Hoelzinger, T. Demuth, K. R. Ross, T. Berens, S. W. Coons, G. Watts, J. M. Trent, J. S. Wei, A. Giese, and M. E. Berens. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: A cDNA microarray analysis. J. Neurooncol. 53:161-176, 2001.
13. Maynard, H. D., S. Y. Okada, and R. H. Grubbs. Synthesis of norbornenyl polymers with bioactive oligopeptides by ringopening metathesis polymerization. Macromolecules 33:6239-6248, 2000.
14. Maynard, H. D., S. Y Okada, and R. H. Grubbs. Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynor-bornenes. J. Am. Chem. Soc. 123:1275-1279, 2001.
15. Molema, G. Drug targeting: Basic concepts and novel advances. In: Drug Targeting: Organ Specific. Strategies, edited by G. Molema and D. K. Meijer. Weinheim: Wiley, 2001, pp. 1-22.
16. Olivier, V., I. Meisen, B. Meckelein, T. R. Hirst, J. PeterKatalinic, M. A. Schmidt, and A. Frey. Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems. Bioconjug. Chem. 14:1203-1208, 2003.
17. Perelson, A. S. Some mathematical models of receptor clustering by multivalent ligands. In: Cell Surface Dynamics: Concepts and Models, edited by A. S. Perelson, C. DeLisi, and F. W. Wiegel. New York: Marcel Dekker, 1984, pp. 223-276.
18. Ramanathan, M., B. Weinstock-Guttman, L. T. Nguyen, D. Badgett, C. Miller, K. Patrick, C. Brownscheidle, and L. Jacobs. In vivo gene expression revealed by cDNA arrays: The pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116(2):213-219, 2001.
19. Sakhalkar, H. S., M. K. Dalal, A. K. Salem, R. Ansari, J. Fu, M. F. Kiani, D. T. Kurjiaka, J. Hanes, K. M. Shakesheff, and D. J. Goetz. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 100(26): 15895-15900, 2003.
20. Sawyer, T. K., P. J. Sanfilippo, V. J. Hruby, M. H. Engel, C. B. Heward, J. B. Bumett, and M. E. Hadley. 4-Norleucine, 7-D-phenylalanine-a-melanocyte-stimulating hormone: A highly potent of-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U.S.A. 77(10):5754-5758, 1980.
21. Shadidi, M., and M. Sioud. Selective targeting of cancer cells using synthetic peptides. Drug Resist. Updates 6:363-371, 2003.
22. Vagner, J., H. L. Handl, R. J. Gillies, and V. J. Hruby. Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: Homooligomers of alpha-MSH. Bioorg. Med. Chem. Lett. 14:211-215, 2004.
23. Wang, X. Z., X. C. Chen, Y. X. Chen, L. J. Zhang, D. Li, F. L. Chen, Z. X. Chen, H. Y. Chen, and Q. M. Tao. Overex-pression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system. World J. Gastroenterol. 9(12):2671-2675, 2003.